Lupin Targets First Wave of Generic GLP-1 Drugs
Lupin Pharmaceuticals aims to be among the first generic drugmakers to launch GLP-1 receptor agonists, drugs used for treating Type II diabetes and obesity, as part of its broader strategy for market expansion. The company revealed plans to enter this …